These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31347707)

  • 1. The behaviour of some antihypertension drugs on human serum paraoxonase-1: an important protector enzyme against atherosclerosis.
    Demir Y
    J Pharm Pharmacol; 2019 Oct; 71(10):1576-1583. PubMed ID: 31347707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition effects of some sulfonamides on human serum paraoxonase-1 (hPON1).
    Demir Y; Köksal Z
    Pharmacol Rep; 2019 Jun; 71(3):545-549. PubMed ID: 31109643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the impacts of antibiotic drugs on PON 1; a major bioscavenger against cardiovascular diseases.
    Ekinci D; Beydemir S
    Eur J Pharmacol; 2009 Sep; 617(1-3):84-9. PubMed ID: 19577563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.
    Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
    Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.
    Imga NN; Topcuoglu C; Berker D; Turhan T
    Arch Med Res; 2018 Apr; 49(3):182-190. PubMed ID: 30031631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naphthoquinones, benzoquinones, and anthraquinones: Molecular docking, ADME and inhibition studies on human serum paraoxonase-1 associated with cardiovascular diseases.
    Demir Y
    Drug Dev Res; 2020 Aug; 81(5):628-636. PubMed ID: 32232985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Dense Low Density Lipoprotein Cholesterol, Paraoxonase 1 and Lipid Profile in Postmenopausal Women: Quality or Quantity?
    Mogarekar MR; Kulkarni SK
    Arch Med Res; 2015 Oct; 46(7):534-8. PubMed ID: 26348135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance.
    Agirbasli M; Tanrikulu A; Erkus E; Azizy M; Sevim BA; Kaya Z; Taskin A; Aksoy N; Demirbag R
    Acta Cardiol; 2014 Dec; 69(6):679-85. PubMed ID: 25643439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects.
    Akbas HS; Basyigit S; Suleymanlar I; Kemaloglu D; Koc S; Davran F; Demir I; Suleymanlar G
    Lipids Health Dis; 2010 Aug; 9():92. PubMed ID: 20804546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase-1 is a better indicator than HDL of Atherosclerosis - A pilot study in North Indian population.
    Singh K; Singh R; Chandra S; Tyagi S
    Diabetes Metab Syndr; 2018 May; 12(3):275-278. PubMed ID: 29254890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
    Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
    Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of HDL-bound and free PON1 on copper-induced LDL oxidation.
    Bayrak A; Bayrak T; Bodur E; Kılınç K; Demirpençe E
    Chem Biol Interact; 2016 Sep; 257():141-6. PubMed ID: 27510818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some Anticancer Agents Act on Human Serum Paraoxonase-1 to Reduce Its Activity.
    Alim Z; Beydemir Ş
    Chem Biol Drug Des; 2016 Aug; 88(2):188-96. PubMed ID: 26873069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.
    Rosenblat M; Gaidukov L; Khersonsky O; Vaya J; Oren R; Tawfik DS; Aviram M
    J Biol Chem; 2006 Mar; 281(11):7657-65. PubMed ID: 16407304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of selective serotonin reuptake inhibitors on paraoxonase-1 enzyme activity: An in vitro study.
    Demir Y; Balcı N; Gürbüz M
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Dec; 226():108608. PubMed ID: 31422163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase, a cardioprotective enzyme: continuing issues.
    Getz GS; Reardon CA
    Curr Opin Lipidol; 2004 Jun; 15(3):261-7. PubMed ID: 15166781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity.
    Yılmaz A; Dilek E
    Protein Pept Lett; 2019; 26(3):215-220. PubMed ID: 30678610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of beta blockers atenolol, nadolol, pindolol, and propranolol on lipoprotein metabolism in normolipemic subjects.
    Harvengt C; Heller FR; Martiat P; Van Nieuwenhuyze Y
    J Clin Pharmacol; 1987 Jul; 27(7):475-80. PubMed ID: 2888790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.